SBIO

•

Equity

INVESCO NASDAQ BIOTECH UCITS ETF

TER (bps):

40

AUM (USD m):

626

ISIN:

IE00BQ70R696

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

United States

As of:

02 Apr 2024

Climate Fund:

No

Benchmark

The NASDAQ Biotechnology Index contains securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals which also meet other eligibility criteria. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo

RELATED ARTICLES

Biotechnology
Analysis

What are biotech ETFs? Investing in innovative healthcare technology

The benefits and risks of investing in these ETFs

Kent Thune

a tree in a desert
Analysis

Citi: Concentrated thematic ETF ownership can impact liquidity

ETFs collectively own over 20% of some small cap companies as a result of rising demand for thematic strategies

Tom Eckett

MOST READ

1
Industry Updates

BlackRock world ETF flash crashes on Deutsche Boerse as liquidity vanishes

Theo Andrew

2
Analysis

Which sectors and factors outperform in wartime?

Nicolas Rabener

3
Opinion

How to make an ‘index-plus’ fund that actually works

Simon Evan-Cook

4
Interview

abrdn eyes quant-based active ETFs to beat thematic data challenges

Theo Andrew

5
New Listing

LGIM launches energy transition commodities ETF

Lauren Gibbons